CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

Phase 1 Investigational New Drug (IND) Navigator

Phase 1Neutral
AI Analysis

Summary

FDA provides Phase 1 IND Navigator, a resource offering tools, guidance, and regulatory expertise for preparing and submitting Investigational New Drug applications.

Importance:1/10
Sentiment:
0.00
INDPhase 1RegulatoryGuidance

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on October 9, 2026 5:54 PM

Read Original